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Aims. To develop a program to support behaviour changes for women with a history of Gestational Diabetes Mellitus (GDM) and
a Body Mass Index (BMI) > 25 kg/m2 to delay or prevent Type 2 Diabetes Mellitus.Methods. Women diagnosed with GDM in the
previous 6 to 24 months and BMI > 25 kg/m2 were randomized to an intervention (I) (𝑛 = 16) or a control (C) (𝑛 = 15) group.
The intervention was a pedometer program combined with nutrition coaching, with the primary outcome increased weight loss
in the intervention group. Secondary outcomes included decreased waist and hip measurements, improved insulin sensitivity and
body composition, increased physical activity, and improved self-efficacy in eating behaviours. Results. Median (IQR) results were
as follows: weight: I −2.5 (2.3) kg versus C +0.2 (1.6) kg (𝑃 = 0.009), waist: I −3.6 (4.5) cm versus C −0.1 (3.6) cm (𝑃 = 0.07), and
hip: I −5.0 (3.3) cm versus C −0.2 (2.6) cm (𝑃 = 0.002). There was clinical improvement in physical activity and eating behaviours
and no significant changes in glucose metabolism or body composition. Conclusion. A pedometer program and nutrition coaching
proved effective in supporting weight loss, waist circumference, physical activity, and eating behaviours in women with previous
GDM.
1. Introduction
Gestational diabetes mellitus (GDM) is a well-established
predictor for the development of type 2 diabetes (T2DM)
[1]. The incidence of GDM has been increasing over the
last fifteen years [2], and, with the introduction of updated
clinical guidelines for the diagnosis and management of
GDM, the prevalence in Australia could be as high as 13% [3].
Worldwide, the prevalence of T2DM following GDMmay be
as high as 70% [4–9].
In 2007, the economic burden of T2DM was estimated
at approximately $US218 billion [10]. The global burden of
T2DM is immense [11] with one potential solution being
a targeted delay or prevention of progression to T2DM in
high risk populations [12–15]. However, programs designed
to target women following GDM have met with varied levels
of success [16]. Lifestyle intervention trials incorporating
dietarymodification and promoting increased physical activ-
ity to support weight loss have been successful in preventing
T2DM [16–19], demonstrating a reduced risk of progression
to T2DM in high risk groups by up to 58% [20, 21], with a
continuing influence up to eight years after the intervention
[22].
In a secondary analysis of the US Diabetes Prevention
Program study, women with documented prior GDM had a
71%greater chance of progressing toT2DMthree years later, a
Hindawi Publishing Corporation
International Journal of Endocrinology
Article ID 423717
2 International Journal of Endocrinology
risk which was reduced by 50% through lifestyle intervention
[18]. However, womenwere over a decade from their delivery,
and it was not known whether this last delivery was in
fact their GDM delivery. Therefore, although interventions
successfully reduced the incidence of diabetes, the onset
of diabetes likely occurred after subsequent pregnancies.
Surveys of women with GDM suggest that six months–two
years is an optimal time to offer a lifestyle modification
intervention as women felt they would be more able to
include changes in their life after the birth of their baby
[23], and earlier intervention would also offer the chance
to reduce the risk of glucose intolerance during subsequent
pregnancies. Targeting these reproductive-aged women with
recognised risk factors with programs that both engage
and provide education for long-term healthy behaviour may
provide the optimal prevention strategy for both maternal
and fetal outcomes.
A recent systematic review examined types of physical
activity and found the most successful exercise programs in
postpartumwomenwere those with objectively set goals usu-
ally incorporating devices such as pedometers [24]. Previous
studies that specifically used pedometers in the postpartum
population report an increase in physical activity [25, 26].
Both studies relied on self-reporting of step counts from
the pedometer, with no indication as to whether the women
would have preferred web-based storage of the step data. Kim
et al. suggested the combination of internet based support
with a more traditional approach may be more successful
than the internet support alone [27].
2. Objectives
This study aimed to develop, implement, and evaluate a low
intensity exercise and diet program for women who were
diagnosed with GDM during a prior pregnancy and had
a body mass index (BMI) > 25 kg/m2 in the postpartum
period. Our primary hypothesis was that the women in the
intervention group would achieve significantly more weight
loss than the control group. Our secondary hypotheses were
that, compared with women in the control group, women
in the intervention group would have significantly (1) better
diet quality and self-efficacy, (2) more minutes of physical
activity/week, (3) lower fasting glucose and insulin levels, and
(4) lower body fat mass (FM) and significantly higher fat free
mass (FFM). The trial was named “walking for exercise and
nutrition to prevent diabetes for you” (WENDY).
3. Method
The intervention took place at a tertiary maternity hospital
in Brisbane, Australia, from June 2011 to December 2012.
The study was approved by Mater Health Services Human
Research Ethics Committee and The University of Queens-
land Medical Research Ethics Committee.
We evaluated the intervention using a randomised con-
trolled trial. Women were eligible if they were 18 years of age
or over and had been diagnosed and treated for GDM, six
months to two years postpartum, had a self-reported BMI >
25 kg/m2, had routine access to a computer, computer skills
to navigate websites, and e-mail, and understood that the
primary physical activity would be walking. Women were
ineligible if they were currently pregnant, had T2DM, were
not fluent in English, used hypoglycaemic medications, or
had any mental or physical disabilities which would have
hindered participation in study activities. Randomisationwas
stratified according to BMI (25–30 kg/m2; >30 kg/m2).
Women were recruited through several venues, includ-
ing telephone contact obtained from the hospital database
of women with GDM diagnoses, hospital-based electronic
resources, advertisements placed through the Australian
National Diabetes Services Scheme (NDSS) [28] dedicated
website to GDM (You2), and television advertisements.
Participants were contacted by the research team, with
three attempts at contact (fixed and mobile phones). Women
not contactable after three attempts were classified as “unable
to contact.” Those who were contacted and refused had their
reasons for refusal noted. For those who agreed to participate,
an e-mail address and basic data such as height and weight to
allow calculation of current BMI and updated contact details
were collected, and an oral glucose tolerance test (OGTT)was
performed to exclude T2DM.
4. Randomisation
An independent service generated a stratified, variable block,
computer generated randomisation schedule and sealed the
individual allocations in opaque envelopes. The envelopes
were stored in a locked, secured container until eligibility was
established. Once eligibility was established through baseline
measurements (BMI, noT2DMonOGTT), the next envelope
for the appropriate stratum was opened.
Women allocated to the intervention group received a
pedometer linked to a tailored web-based program “step up
to health” and a four-week nutrition coaching workshop.
The women in the control group formed a wait-list group
and were offered the nutrition workshop following the three-
month assessment.
The pedometer had an opaque sticker that covered the
digital display and was worn continuously for the first week,
without providing feedback to record baseline steps. Once
the baseline steps were uploaded via USB, the sticker was
removed and the step count was visible. The web-based
program generated weekly goals based on the previous weeks
steps. As the steps were uploaded each week, the goals were
gradually increased, until the maximum of 10,000 steps/day
was reached [27]. The user was encouraged to log on weekly
to receive updated weekly goals, feedback on their walking
progress, messages, and “tips” regarding diet and exercise
targeted at diabetes prevention.
The nutrition coaching workshop was delivered by
accredited practising dietitians. The workshop consisted of
four one-hour group sessions incorporating evidence-based
strategies to facilitate behaviour change aimed at healthy
sustainable weight loss [29] and to build self-efficacy such as
goal setting and self-monitoring and use of group activities to
model recommended behaviour and engender peer support.
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Resources provided to all women included tools designed to
encourage portion control [30, 31].
5. Data Collection and Outcome Measures
Data were collected at baseline and three months. Baseline
observations included survey-based assessments of dietary
and physical activity, mental health assessments, assessments
of anthropometrics, body composition, serum insulin, and
OGTT performance. Weight was measured to the nearest
0.1 kg using a spring balance scale, and height was measured
with a wall mounted stadiometer to the nearest 0.5 cm. Hip
and waist measurements were taken with a standard tape
measure, and estimation of body composition (fat mass and
lean body mass) was assessed using using a multifrequency
bioelectrical impedance analyser (BodyStat 1500MDD,Body-
stat, United Kingdom), with a measured resistance at a fixed
frequency of 50Hz.
Dietary quality was assessed using the Fat, Fibre Index
[32], eating behaviour self-efficacy was assessed using The
Health and Wellbeing Self Efficacy Survey (WEL) [33],
physical activity was assessed using Australian Women’s
Activity Survey (AWAS) [34], andmental health was assessed
using the Kessler Psychological Distress scale (K10) [35]. Any
results indicative of anxiety or depressionwere discussedwith
the participant and referred to relevant health care providers
if necessary [36]. The homeostasis model assessment of
insulin resistance (HOMA-IR), a widely used estimate of
insulin resistance in the fasting state, was calculated as fasting
plasma insulin (FPI)-[mU/L] × fasting plasma glucose (FPG)
[mmol/L]/22.5 [37].
6. Outcome Measures
The primary outcome was weight loss from baseline to three
months, reported as absolute weight loss for each participant.
Secondary outcomes were change in measurements from
baseline to three months for (1) hip and waist measurements,
(2) diet quality measured by a self-reported survey, (3)
WEL overall and domain scores, (4) minutes of physical
activity/week (as health enhancing physical activity, HEPA),
(5) glucose and HOMA-IR, and (6) body FM and FFM.
7. Statistical Methods
Analysis was by intention-to-treat with all analyses com-
paring the control and intervention groups. Analysis was
undertaken with blinding to study assignment.
Data were checked for normality of the distributions of
continuous variables. Normally distributed variables under-
went parametric analyses; continuous non-normally dis-
tributed data were analyzed using nonparametric methods
and categorical data were analyzed using chi-squared or
Fisher’s exact test. Analysis of the primary outcome used
independent samples 𝑡-test, examining percentage of weight
loss between the control and intervention groups. Analyses
were performed in SPSS version 15 [38]. Results are reported
Table 1: Demographic characteristics of women in intervention and
control groups.
Characteristic Group Total𝑁 = 31
Age at OGTT∗ (years) 36.0 (4.5)Range 28–44
Ethnicity Caucasian 28 (90%)
Other 3 (10%)
Health insurance status Public (NHS) 17 (55%)
Privately funded 14 (45%)
Gravidity 1 6 (19%)
2+ 25 (81%)
Parity 0 6 (19%)
1+ 25 (81%)
Diabetic control with GDM
Insulin 19 (61%)
Metformin 4 (13%)
Diet 8 (26%)
Weight∗ (kg) 85.7 (17.5)
BMI∧ (kg/m2) 30.3 (8.2)
Waist∗ (cm) 100.7 (11.8)
Hip∗ (cm) 116.6 (14.1)
Body fat %∗ 37.4 (7.1)
Lean mass %∗ 52.5 (6.2)
Fasting glucose∧ 4.8 (0.8)
Fasting insulin∧& 8.7 (6.0)
2 hr glucose∧ 5.5 (2.8)
∗Mean (standard deviation), independent samples 𝑡-test.
∧Median (interquartile range), Mann-Whitney 𝑈 test.
&4 cases missing (1 intervention; 3 control).
as mean (standard deviation [SD]) or median (interquartile
range [IQR]).
8. Results
Demographic and anthropometric characteristics of the
study participants were similar in each group (Table 1).There
were more multigravidas in the intervention group, and an
equal proportion of women had public and private health
insurance. Ethnicity was predominately Caucasian women,
with three women of Asian descent. The majority of women
had required insulin therapy (control 𝑛 = 10 [67%],
intervention 𝑛 = 9 [56%]) to control their glucose levels
during pregnancy, followed by diet (control 𝑛 = 4 [27%],
intervention 𝑛 = 4 [25%]) and thenmetformin (control 𝑛 = 1
[7%], intervention 𝑛 = 3 [19%]).
We attempted to contact two hundred and forty-six
women (Figure 1).Thirty-one women were randomised, with
twenty-three women completing the three-month primary
outcome measurements.
Five participants in the intervention group discontinued
over the course of the 3-month period for differing reasons
(Figure 1). One control participant (who was randomised in
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Enrollment
↓
Assessed for eligibility n = 576
No phone contact n = 256
∙ Disconnected n = 130
∙ Unable to contact n = 126
Participants contacted n = 320
Intervention n = 16 Control n = 15
Randomized n = 31
Three-month visit n = 11 (69%)
Discontinued intervention n = 5
∙ Too busy n = 2
∙ Work commitments n = 1
∙ Unable to recontact n = 2
Three-month visit n = 12 (80%)
Discontinued control n = 3
∙ Current diabetes n = 1
∙ Became pregnant and decided to withdraw
n = 1
∙ Too busy n = 1
Declined to participate n = 81
∙ Too far from hospital n = 27
∙ Too busy n = 11
∙ Not interested n = 27
∙ Already in a program n = 4
∙ Did not have GDM n = 6
∙ Working n = 3
∙ Other n = 3
Not meeting inclusion criteria n = 208
∙ BMI > 25 n = 71
∙ Currently pregnant n = 35
∙ Current diabetes n = 8
∙ Maternal death n = 1
∙ Limited English n = 22
∙ IUFD n = 1
∙ Baby > 2yrs n = 58
∙ Outside catchment area n = 12
Figure 1: Consort diagram of the study.
error prior to OGTT results) was diagnosed as T2DM follow-
ing baseline OGTT and two other participants withdrew for
unspecified reasons. Eleven participants in the intervention
group (69%) and 12 participants in the control group (80%)
completed both baseline and three-month assessments.
Weight loss was greater in the intervention group, with a
median loss of 2.5 kg (1.4) compared with a static weight in
the control group (𝑃 = 0.002), leading to a reduction in BMI
of 0.9 kg/m2 (IQR 0.7) (𝑃 = 0.002) in the intervention group
(Table 2).
9. Secondary Outcomes
Changes in hip circumference were also significant with a
median loss of 3 cm (5.0) in the intervention group compared
with 0 cm (4.8) (𝑃 = 0.006). Intervention group waist
circumference decreased by amedian of 3 cm (4.0) compared
with 0.5 cm (4.8) (𝑃 = 0.037).
There was a slight decrease in body fat and increase
in lean body mass in the intervention group, but this was
not statistically significant. Fasting glucose taken at both
data collection points showed a small difference between the
two groups that had borderline statistical significance (𝑃 =
0.052); however, there was no change in HOMA-IR.
The intervention group increased their daily activity by
one hundred and thirty-five minutes/week at the three-
month time point compared to the control group, although
this difference was not statistically significant. The WEL
results showed participants in the intervention group at three
months feeling empowered when presented with opportu-
nity for poor food choices (𝑃 = 0.036). Despite being
not statistically significant, trends towards improvements in
the domains of negative emotions, social pressure, physical
discomfort, and positive activities were noted, all related to
the participants’ feelings regarding food and food choices
(Table 2). There were no differences in factors related to
depression or mood changes between groups.
10. Website ‘‘Stepping up to Health’’
All women randomised to the intervention group accessed
the website during the three-month intervention. The mean
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Table 2: Change between 3-month and baseline measurements.
Characteristic Intervention
𝑁 = 11
Control
𝑁 = 12
𝑃-value
Weight∧ (kg) −2.5 (1.4) 0.0 (2.3) 0.002
BMI∧ (kg/m2) −0.9 (0.7) 0.0 (0.8) 0.002
Waist∧ (cm) −3.0 (4.0) 0.5 (4.8) 0.037
Hip∧ (cm) −3.0 (5.0) 0.0 (4.8) 0.006
Body fat %∧& −1.1 (4.5) −0.3 (1.3) 0.393
Lean mass %∧& 0.9 (3.3) 0.0 (2.6) 0.436
Fasting glucose∧& 0.3 (0.5) −0.1 (0.6) 0.052
Fasting insulin∧# −0.5 (2.4) 0.173 0.830
K 10 total score∧
(measure of distress
and anxiety over the
previous month)
0.0 (4.0) 1.0 (4.0) 0.193
WEL total score
(measure of attitudes,
feelings, and efficacy
related to food and
eating behaviours)
27.8 (20.1) 13.9 (37.4) 0.290
Negative emotions 5.5 (2.9) 3.5 (8.5) 0.472
Availability 7.1 (5.5) 1.0 (7.0) 0.036
Social pressure 6.1 (5.4) 4.1 (9.4) 0.545
Physical discomfort 4.5 (6.7) 4.5 (8.4) 0.978
Positive activities 4.6 (4.9) 0.9 (7.6) 0.188
HEPA 135 (225) 0 (418) 0.190
Fat 0.2 (0.4) 0.2 (0.5) 0.824
Fibre −0.04 (0.8) 0.1 (0.4) 0.576
Total 0.1 (0.5) 0.2 (0.4) 0.682
All results are mean (standard deviation) unless otherwise stated.
∧Median (interquartile range), Mann-Whitney 𝑈 test.
&3 cases missing (1 intervention; 2 control).
#5 cases missing (1 intervention; 4 control).
Table 3: Pedometer and nutrition workshop data.
Characteristic Mean (SD) Range
Number of times
pedometer data
uploaded
90 (31) 39–145
Number of days where
steps were recorded
71 (31) 30–109
Number of steps per day 4,687 (3,510) 0–16,645
Number of times website
messages accessed
28 (26) 3–74
Number of nutrition
workshops attended
3 (1) 0–4
SD: standard deviation.
number of participant pedometer uploads was 90 (SD 31).
The mean recorded steps/day were 5,916 (SD 2,878, range 5–
16,645) in the three-month period (Table 3).
11. Discussion
AlthoughwomenwithGDMare at increased risk for diabetes
and a significant proportion will develop T2DM within the
decade after their GDM delivery, interventions successfully
targeting women during this time are few. In this study, we
demonstrate that a simple, brief intervention consisting of
only 4 sessions of counseling and a web-based activity com-
ponent could successfully reduce weight, increase physical
activity, and improve constructs associated with improved
lifestyle behaviours. Such a program has the potential to be
delivered in multiple care settings for limited cost. However,
our study also demonstrates the challenges of engaging
women with young children in an intervention aimed at
changing lifestyle behaviours, as willingness to participate in
the relatively “simple” intervention was low.
Obesity is a primary risk factor for the development of
T2DM [1]. At least two systematic reviews [39, 40] have
suggested that a combination of diet and exercise rather than
diet alone may be more efficacious for postpartum weight
loss [24, 39, 40]. A previous report using only the web-based
pedometer component targeting physical activity did not
demonstrate significant weight loss [27], suggesting that both
diet and exercise components are necessary, even though
we did not note significant changes in dietary quality. Of
note, the pattern of clinically significant changes in physical
activity with smaller, nonsignificant diet quality changes was
also observed in recent dietary and physical intervention
underpinned by similar behaviour-change strategies for high
BMI women in the postpartum period [41]. The results for
the secondary outcomes in our study such as the trend of
increased incidental activity and improved self-efficacy in
food behaviour in the intervention group may be a collateral
effect of goal setting behaviour. The value of increased
physical activity in all domains is an important factor in
overall lifestyle change.
Our study also suggests that an in-person counseling
component may be more effective for behaviour change in
this specific at-risk group of women than the web-based
program alone. The mean attendance in the four counseling
sessions was three (range 0–4 sessions) (Table 3) with the
majority of participants attending all four group sessions.
These results suggest that the primary impact of the interven-
tion was mediated through the in-person counseling session.
Other interventions targeting obesity and risk reduction
of T2DM have noted that behaviour may be successfully
modified by counseling sessions only [17], but participant
populations in those studies were older and had different
motivators and enablers of behaviour change.
Recruitment of participants in the early postpartum
phase has been proven to be difficult. Although we demon-
strated promising weight and behaviour changes amongst
participants, it is also notable that the participation was low
and needed extensive advertising and outreach to obtain
the small numbers enrolled in this study. Common themes
encountered by other intervention studies in this population
such as lack of time, no childcare, and difficulties “fitting
the changes” into the family were also a factor in this study
and affected all stages of the project from recruitment of
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possible participants and attrition during the trial to poor
followup attendance [27, 42, 43]. While the intervention
was designed to reduce barriers to behaviour change, this
experience suggests that additional motivators will need to
be explored in order to successfully change behaviour in this
group of young mothers.
The strength of our study lies in the physical and lifestyle
changes achieved in the intervention group of our sample.
The feedback from the participants on the combination of
the pedometer and website was positive and the delivery and
content of the nutrition workshop were well received. The
ability to provide the intervention in a central location was
also a strength as most women found the hospital a familiar
environment.
There were limitations in this project. Despite our efforts
to recruit a larger number of participants, actual recruitment
was low; therefore, the statistical power to detect significant
differences between intervention and control arms was lim-
ited. Moreover, the women in this study were predominantly
Caucasian and in their mid-thirties, and thus our results may
not apply to women of other age or racial/ethnic groups.
Younger women may have lower perceptions of risk and
less motivation to alter behaviour [44, 45], and women of
other races/ethnicities may have different perceptions and
understanding of lifestyle changes required to decrease their
risk of developing T2DM [46].
12. Conclusion
Despite encountering similar barriers to recruitment and
retention of participants as in other intervention trials, results
from this study demonstrate that the combination of a
web-based pedometer intervention with nutrition coaching
underpinned by behaviour change theory based on long-
term behaviour change can lead to overall weight loss and
increased physical activity (known risk factors for the devel-
opment of T2DM)over a three-month period.The availability
of a program that combines these features in a suitably
delivered format to engage women previously diagnosedwith
GDM in a larger scale trialmay delay or prevent T2DM in this
high risk group.
This trial is registered with Australia and New Zealand
Clinical Trials registry ACTRN12611000075987.
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